The Helsinki University Hospital Cancer Center is the largest cancer treatment center in Finland and one of the largest in the EU. More than 3,000 patients come for pharmacotherapy annually. Radiotherapy is administered to more than 3,500 patients, and the number of treatment visits is more than 65,000.

In 2014, the Cancer Center was the first in the Nordic countries to receive the highest possible accreditation of “Comprehensive Cancer Center” from the Organisation of European Cancer Institutes (OECI) in recognition of exceptionally high quality throughout the treatment chain. Only one other university hospital in Europe, namely Cambridge, has achieved a similar status of the highest excellence.

Although being an issue of oncology, cancer treatment involves multi-professional collaboration. At leading cancer centers, no single doctor treats all possible types of cancer; rather, each physician focuses on a certain group of tumors and treatment procedures. The Cancer Clinic has tumor teams that focus on the examinations and treatments of the various cancers.

Being in charge of cancer research and diagnoses as well as planning and delivering treatments, the oncologists at the Cancer Center play a key role in cancer treatment. Treatment methods include radiotherapy, cytostatics and other pharmacotherapies as well as hormonal treatments.

Surgical treatment of cancer is delivered in specialized clinics at the university hospital by top surgical treatment experts in close collaboration with the Cancer Center’s oncologists and other experts.

We provide treatments for the following types of cancers: oncological treatment of breast cancer, prostate cancer, brain tumors, thyroid cancer, melanoma, colorectal cancer, kidney cancer and neuroendocrine tumors, to mention a few. Thanks to our special expertise, we are able to offer treatments also for less common tumors, such as GISTs. We also provide other services associated with oncology. More information is available at our Customer Service.


Boron-neutron capture therapy (BNCT) is biolo­gically targeted form of radiation therapy. The therapy has been used to treat, for instance, locally advanced head and neck cancers.

The Helsinki University Hospital Compre­hensive Cancer Center will receive Neutron Thera­peu­tics’ first BNCT accele­rator ever designed to be used in a hospital.

Both Finnish and foreign head and neck cancer patients are expected to receive BNCT treatment at the facility in 2019/2020. Read more by clicking BNCT-link below.